Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia
Chih-Hsiang Yu
(Institute of Statistical Science Academia Sinica)
Ya-Hsuan Chang
(Institute of Statistical Science Academia Sinica)
Der-Shiun Wang
(Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center)
Shiann-Tarng Jou
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Chien-Yu Lin
(Institute of Statistical Science Academia Sinica)
Kai-Hsin Lin
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Meng-Yao Lu
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Kang-Hsi Wu
(Department of Pediatrics, Chung Shan Medical University Hospital)
Chao-Neng Cheng
(Department of Pediatrics, National Cheng Kung University Hospital)
Hsiu-Hao Chang
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Shu-Wei Chou
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Min-Yu Su
(Department of Pediatrics, China Medical University Children’s Hospital)
Yu-Ling Ni
(Department of Laboratory Medicine, National Taiwan University Hospital)
Pei-Yuan Xu
(Department of Laboratory Medicine, National Taiwan University Hospital)
Dong-Tsamn Lin
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Shu-Wha Lin
(Departments of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University)
Hsuan-Yu Chen
(Institute of Statistical Science Academia Sinica)
Yung-Li Yang
(Department of Pediatrics, National Taiwan University Children’s Hospital)
Abstract Mercaptopurine intolerance is an adverse effect of mercaptopurine administration in pediatric patients with acute lymphoblastic leukemia (ALL). NUDT15 variants have emerged as major determinants of mercaptopurine intolerance, especially in the Asian population. Two variants, c.55_56insGAGTCG in exon 1 and c.415C > T in exon 3, were commonly detected in the same allele, named NUDT15*1/*2. Although rare, compound heterozygous mutations also occur, with the two variants on different alleles (NUDT15*3/*6), which may confer tolerance to considerably lesser mercaptopurine dosage. Sanger sequencing or pyrosequencing can determine the NUDT15 variants but not the phase. Here, we designed an allele-specific PCR (AS-PCR) with locked nucleic acid-modified primers. A cohort of 63 patients harboring heterozygous c.55_56insGAGTCG and c.415C > T NUDT15 variations was selected for haplotyping using AS-PCR. Of the 63 patients, 60 harbored the NUDT15*1/*2 variant and three harbored compound heterozygous mutations, including two NUDT15*3/*6 and one NUDT15*2/*7 variants. These findings suggest that AS-PCR can determine NUDT15 diplotype and identify patients with compound heterozygous NUDT15 variants, which may enable precise genetic diagnosis of NUDT15. Nevertheless, a larger clinical trial is required to understand the clinical significance of NUDT15*3/*6 in pediatric patients with ALL because of its low incidence rate and challenges in detecting this variant.
Chih-Hsiang Yu, Ya-Hsuan Chang, Der-Shiun Wang, et al. (2023). "Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia". Scientific Reports. https://doi.org/10.1038/s41598-023-27720-2